«CASL Biography». Consultado em 1 de fevereiro de 2009. Arquivado do original em 6 de outubro de 2011 and «CASL History». Consultado em 1 de fevereiro de 2009. Arquivado do original em 6 de outubro de 2011
Laursen TM; Munk-Olsen T, Vestergaard M (Março de 2012). «Life expectancy and cardiovascular mortality in persons with schizophrenia». Current opinion in psychiatry. 25 (2): 83–8. PMID22249081. doi:10.1097/YCO.0b013e32835035ca
GBD 2015 Mortality and Causes of Death, Collaborators. (8 de outubro de 2016). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1459–1544. PMID27733281. doi:10.1016/s0140-6736(16)31012-1
Kavanagh, D H; Tansey, K E; O'Donovan, M C; Owen, M J (2014). «Schizophrenia genetics: emerging themes for a complex disorder». Molecular Psychiatry. 20 (1): 72–76. ISSN1359-4184. doi:10.1038/mp.2014.148 !CS1 manut: Nomes múltiplos: lista de autores (link)
Becker T; Kilian R (2006). «Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care?». Acta Psychiatrica Scandinavica Supplement. 113 (429): 9–16. PMID16445476. doi:10.1111/j.1600-0447.2005.00711.x
Global Burden of Disease Study 2013 (5 de junho de 2015). «Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.». Lancet (Londres, Inglaterra). PMID26063472. doi:10.1016/S0140-6736(15)60692-4
Foster, A; Gable, J; Buckley, J (Setembro de 2012). «Homelessness in schizophrenia.». The Psychiatric clinics of North America. 35 (3): 717–34. PMID22929875. doi:10.1016/j.psc.2012.06.010
Hor K; Taylor M (Novembro de 2010). «Suicide and schizophrenia: a systematic review of rates and risk factors». Journal of psychopharmacology (Oxford, Inglaterra). 24 (4 Suppl): 81–90. PMID20923923. doi:10.1177/1359786810385490
Tienari P, Wynne LC, Läksy K,; et al. (setembro de 2003). «Genetic boundaries of the schizophrenia spectrum: evidence from the Finnish Adoptive Family Study of Schizophrenia». The American Journal of Psychiatry. 160 (9): 1587–94. PMID12944332. doi:10.1176/appi.ajp.160.9.1587 !CS1 manut: Nomes múltiplos: lista de autores (link)
Laursen TM; Munk-Olsen T, Vestergaard M (Março de 2012). «Life expectancy and cardiovascular mortality in persons with schizophrenia». Current opinion in psychiatry. 25 (2): 83–8. PMID22249081. doi:10.1097/YCO.0b013e32835035ca
GBD 2015 Mortality and Causes of Death, Collaborators. (8 de outubro de 2016). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1459–1544. PMID27733281. doi:10.1016/s0140-6736(16)31012-1
Becker T; Kilian R (2006). «Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care?». Acta Psychiatrica Scandinavica Supplement. 113 (429): 9–16. PMID16445476. doi:10.1111/j.1600-0447.2005.00711.x
Global Burden of Disease Study 2013 (5 de junho de 2015). «Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.». Lancet (Londres, Inglaterra). PMID26063472. doi:10.1016/S0140-6736(15)60692-4
Foster, A; Gable, J; Buckley, J (Setembro de 2012). «Homelessness in schizophrenia.». The Psychiatric clinics of North America. 35 (3): 717–34. PMID22929875. doi:10.1016/j.psc.2012.06.010
Hor K; Taylor M (Novembro de 2010). «Suicide and schizophrenia: a systematic review of rates and risk factors». Journal of psychopharmacology (Oxford, Inglaterra). 24 (4 Suppl): 81–90. PMID20923923. doi:10.1177/1359786810385490
Tienari P, Wynne LC, Läksy K,; et al. (setembro de 2003). «Genetic boundaries of the schizophrenia spectrum: evidence from the Finnish Adoptive Family Study of Schizophrenia». The American Journal of Psychiatry. 160 (9): 1587–94. PMID12944332. doi:10.1176/appi.ajp.160.9.1587 !CS1 manut: Nomes múltiplos: lista de autores (link)
Verdoux H; van Os J (2002). «Psychotic symptoms in non-clinical populations and the continuum of psychosis». Schizophrenia Research. 54 (1–2): 59–65. PMID11853979
Johns LC; van Os J (2001). «The continuity of psychotic experiences in the general population». Clinical Psychology Review. 21 (8): 1125–41. PMID11702510
Peters ER; Day S, McKenna J, Orbach G (2005). «Measuring delusional ideation: the 21-item Peters et al. Delusions Inventory (PDI)». Schizophrenia Bulletin. 30 (4): 1005–22. PMID15954204 !CS1 manut: Nomes múltiplos: lista de autores (link)
nimh.nih.gov
«Schizophrenia». National Institute of Mental Health. Janeiro de 2016. Consultado em 3 de fevereiro de 2016
«CASL Biography». Consultado em 1 de fevereiro de 2009. Arquivado do original em 6 de outubro de 2011 and «CASL History». Consultado em 1 de fevereiro de 2009. Arquivado do original em 6 de outubro de 2011
Kavanagh, D H; Tansey, K E; O'Donovan, M C; Owen, M J (2014). «Schizophrenia genetics: emerging themes for a complex disorder». Molecular Psychiatry. 20 (1): 72–76. ISSN1359-4184. doi:10.1038/mp.2014.148 !CS1 manut: Nomes múltiplos: lista de autores (link)